Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M40,667Revenue $M2,391Net Margin (%)24.8Altman Z-Score5.8
Enterprise Value $M42,802EPS $2.9Operating Margin %30.3Piotroski F-Score4
P/E(ttm)61.5Beneish M-Score-2.0Pre-tax Margin (%)30.4Higher ROA y-yY
Price/Book4.810-y EBITDA Growth Rate %--Quick Ratio3.0Cash flow > EarningsY
Price/Sales15.25-y EBITDA Growth Rate %52.3Current Ratio3.3Lower Leverage y-yN
Price/Free Cash Flow58.5y-y EBITDA Growth Rate %4.9ROA % (ttm)10.1Higher Current Ratio y-yN
Dividend Yield %--PEG1.1ROE % (ttm)13.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M226ROIC % (ttm)17.6Gross Margin Increase y-yN

Gurus Latest Trades with ALXN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ALXNDavid Swensen 2015-06-30 Buy 16.37%$155.01 - $190.92
($172.58)
$ 177.843%New holding319,273
ALXNJoel Greenblatt 2015-06-30 Sold Out -0.03%$155.01 - $190.92
($172.58)
$ 177.843%Sold Out0
ALXNRon Baron 2015-06-30 Add0.02%$155.01 - $190.92
($172.58)
$ 177.843%Add 69.48%69,764
ALXNMario Gabelli 2015-06-30 Buy $155.01 - $190.92
($172.58)
$ 177.843%New holding1,415
ALXNJoel Greenblatt 2015-03-31 Reduce-0.09%$171.42 - $189.07
($181.01)
$ 177.84-2%Reduce 72.94%23,261
ALXNRon Baron 2015-03-31 Add0.02%$171.42 - $189.07
($181.01)
$ 177.84-2%Add 124.13%41,163
ALXNJoel Greenblatt 2014-12-31 Add0.13%$159.46 - $200.79
($185.68)
$ 177.84-4%Add 4665.74%85,974
ALXNRon Baron 2014-12-31 Add$159.46 - $200.79
($185.68)
$ 177.84-4%Add 41.92%18,366
ALXNJoel Greenblatt 2014-09-30 Reduce-0.03%$155.06 - $173.08
($164.22)
$ 177.848%Reduce 89.45%1,804
ALXNRon Baron 2014-09-30 Add$155.06 - $173.08
($164.22)
$ 177.848%Add 27.56%12,941
ALXNJoel Greenblatt 2014-06-30 Add0.02%$139.61 - $170.2
($157.93)
$ 177.8413%Add 240.11%17,094
ALXNJoel Greenblatt 2014-03-31 Buy 0.01%$129.82 - $183.89
($158.27)
$ 177.8412%New holding5,026
ALXNRon Baron 2014-03-31 Buy 0.01%$129.82 - $183.89
($158.27)
$ 177.8412%New holding10,218
ALXNJoel Greenblatt 2013-03-31 Sold Out -0.07%$83.39 - $102.57
($93.13)
$ 177.8491%Sold Out0
ALXNJoel Greenblatt 2012-12-31 Buy 0.07%$87.97 - $118.15
($98.27)
$ 177.8481%New holding12,977
ALXNGeorge Soros 2012-06-30 Sold Out -0.07%$83.74 - $98.82
($91.04)
$ 177.8495%Sold Out0
ALXNGeorge Soros 2012-03-31 Buy 0.07%$70.29 - $94.31
($75.85)
$ 177.84134%New holding50,000
ALXNJoel Greenblatt 2011-09-30 Sold Out -0.0882%$47.81 - $66.99
($56.19)
$ 177.84216%Sold Out0
ALXNJoel Greenblatt 2011-06-30 Buy 0.09%$44.61 - $52.195
($47.91)
$ 177.84271%New holding13,417
ALXNGeorge Soros 2011-06-30 Sold Out $44.61 - $52.195
($47.91)
$ 177.84271%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ALXN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ALXN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Moriarty John BEVP & General Counsel 2015-08-07Sell135$190.01-8.67view
Carmichael ClareEVP, Chief HR Officer 2015-08-07Sell163$190.01-8.67view
Hallal DavidCEO 2015-08-07Sell329$190.01-8.67view
BELL LEONARDDirector 2015-08-07Sell1,003$190.01-8.67view
Moriarty John BEVP & General Counsel 2015-08-05Sell10,010$198.44-12.55view
Hallal DavidCEO 2015-08-04Sell612$196.52-11.69view
Carmichael ClareEVP, Chief HR Officer 2015-08-04Sell185$196.52-11.69view
Sinha VikasEVP & CFO 2015-08-04Sell675$196.52-11.69view
BELL LEONARDDirector 2015-08-04Sell2,200$196.52-11.69view
MACKAY MARTINEVP & Global Head of R&D 2015-08-03Sell43,500$196.52-11.69view

Quarterly/Annual Reports about ALXN:

News about ALXN:

Articles On GuruFocus.com
David Swensen Buys Stake in Vanguard MSCI Emerging Markets ETF Aug 19 2015 
Baron Funds Comments on Alexion Pharmaceuticals Inc. Aug 19 2015 
Andreas Halvorsen Increases Stake in Esperion Therapeutics Jun 29 2015 
Alexion Acquiring Synageva For $8.4 Billion May 09 2015 
Alexion Pharma Downgraded Despite Progress in Pipeline Jan 05 2015 
Weekly CFO Sells Highlight: Alexion Pharmaceuticals Inc, Equity Residential, Tableau Software Inc. Dec 08 2014 
Weekly Insider Sells Highlight: ORCL, ALXN, WAT, XRAY Dec 08 2014 
CEO of Alexion Pharmaceuticals Sells Company Stock Sep 29 2014 
Alexion CEO Receives Nearly $17 Million for Sale of Company Stock Aug 14 2014 
Weekly CFO Sells Highlight: Facebook Inc., Cardinal Health Inc., Alexion Pharmaceuticals Inc., Therm Feb 10 2014 

More From Other Websites
How Big Biotech Spends Its Money Aug 21 2015
Falling Earnings Estimates Signal Weakness Ahead for Alexion Pharmaceuticals (ALXN) Aug 21 2015
Celgene May be The Single Best Biotech in the World Aug 19 2015
ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Other Events Aug 17 2015
Don’t Miss White-Hot Baker Bros.’ New Healthcare Picks Aug 17 2015
Biotech, Semiconductor ETFs Enter Dangerous Ground Aug 14 2015
Short Sellers Wary Of Biotech Stocks Aug 14 2015
ALEXION PHARMACEUTICALS INC Files SEC form 8-K/A, Financial Statements and Exhibits Aug 13 2015
JPMorgan Has Favorite Biotech Stocks to Buy for Rest of 2015 Aug 13 2015
3 Large Biotech Stocks to Buy Despite Higher Interest Rates Coming Aug 10 2015
What’s Shire’s plan for Baxalta? Inside CEO Flemming Ornskov’s head Aug 07 2015
Will Gilead Make 'Transformative Transaction'? Aug 07 2015
Corruption Currents: Hacking Computers to Send Data Via Sound Waves Aug 06 2015
ALEXION PHARMACEUTICALS INC Financials Aug 06 2015
Amgen, Inc. Earnings Analysis: By the Numbers Q2*, 2015 Aug 06 2015
3 Potential Huge Takeover Targets in Biotech Aug 04 2015
10-Q for Alexion Pharmaceuticals, Inc. Aug 03 2015
ALEXION PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Jul 31 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK